Robin Sherrington
- SEC CIK
- 0001619962
No open-market purchases or sales filed in the past year.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.EVP, Strategy & Innovationas of Mar 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Robin Sherrington as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 (view filing) | Mar 7 | 1 day | Robin SherringtonEVP, Strategy & Innovation | SSale | −7.14K | $46.28 | −$330.3K | −45.9%8.40K after | 2 lots |
| Sep 2, 2022 (view filing) | Aug 31-Sep 1 | 2 days | Robin SherringtonEVP, Strategy & Innovation | SSale | −65.2K | $38.31 | −$2.50M | −79.5%16.8K after | 3 lots |
| Mar 8, 2022 (view filing) | Mar 4 | 4 days | Robin SherringtonEVP, Strategy & Innovation | SSale | −21.7K | $30.50 | −$662.2K | −55.7%17.2K after | 4 lots |